Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.25.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Revenues $ 48,560 $ 41,378
Cost of goods sold 13,627 8,758
Gross profit 34,933 32,620
Costs and expenses:    
Sales and marketing 21,045 19,815
Research and development 6,091 7,409
General and administrative 9,458 9,956
Total costs and expenses 36,594 37,180
Loss from operations (1,661) (4,560)
Other (expense) income:    
Investment income 272 293
Interest expense (2,250) (2,326)
Change in fair value of debt derivative liabilities (158) 65
Other expense (37) (107)
Total other expense, net (2,173) (2,075)
Net loss $ (3,834) $ (6,635)
Weighted average common shares outstanding - basic (in shares) 45,204,076 43,233,149
Weighted average common shares outstanding - diluted (in shares) 45,204,076 43,233,149
Net loss per common share - basic (in USD per share) $ (0.08) $ (0.15)
Net loss per common share - diluted (in USD per share) $ (0.08) $ (0.15)